Global Infectious Disease In-vitro Diagnostic Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Infectious Disease In-vitro Diagnostic market size was estimated at USD 70.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease In-vitro Diagnostic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease In-vitro Diagnostic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease In-vitro Diagnostic market.
Global Infectious Disease In-vitro Diagnostic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BD
BioM?rieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Market Segmentation (by Type)
Immunoassay
Molecular Diagnostics
Microbiology
Others
Market Segmentation (by Application)
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease In-vitro Diagnostic Market
Overview of the regional outlook of the Infectious Disease In-vitro Diagnostic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease In-vitro Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease In-vitro Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Infectious Disease In-vitro Diagnostic market size was estimated at USD 70.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease In-vitro Diagnostic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease In-vitro Diagnostic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease In-vitro Diagnostic market.
Global Infectious Disease In-vitro Diagnostic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BD
BioM?rieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Market Segmentation (by Type)
Immunoassay
Molecular Diagnostics
Microbiology
Others
Market Segmentation (by Application)
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Infectious Disease In-vitro Diagnostic Market
Overview of the regional outlook of the Infectious Disease In-vitro Diagnostic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease In-vitro Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease In-vitro Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Disease In-vitro Diagnostic
1.2 Key Market Segments
1.2.1 Infectious Disease In-vitro Diagnostic Segment by Type
1.2.2 Infectious Disease In-vitro Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Infectious Disease In-vitro Diagnostic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease In-vitro Diagnostic Product Life Cycle
3.3 Global Infectious Disease In-vitro Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease In-vitro Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease In-vitro Diagnostic Market Competitive Situation and Trends
3.8.1 Infectious Disease In-vitro Diagnostic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease In-vitro Diagnostic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease In-vitro Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease In-vitro Diagnostic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease In-vitro Diagnostic Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease In-vitro Diagnostic Market Size by Type (2020-2025)
6.4 Global Infectious Disease In-vitro Diagnostic Price by Type (2020-2025)
7 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease In-vitro Diagnostic Market Sales by Application (2020-2025)
7.3 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease In-vitro Diagnostic Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET SALES BY REGION
8.1 Global Infectious Disease In-vitro Diagnostic Sales by Region
8.1.1 Global Infectious Disease In-vitro Diagnostic Sales by Region
8.1.2 Global Infectious Disease In-vitro Diagnostic Sales Market Share by Region
8.2 Global Infectious Disease In-vitro Diagnostic Market Size by Region
8.2.1 Global Infectious Disease In-vitro Diagnostic Market Size by Region
8.2.2 Global Infectious Disease In-vitro Diagnostic Market Size by Region
8.3 North America
8.3.1 North America Infectious Disease In-vitro Diagnostic Sales by Country
8.3.2 North America Infectious Disease In-vitro Diagnostic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease In-vitro Diagnostic Sales by Country
8.4.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease In-vitro Diagnostic Sales by Region
8.5.2 Asia Pacific Infectious Disease In-vitro Diagnostic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease In-vitro Diagnostic Sales by Country
8.6.2 South America Infectious Disease In-vitro Diagnostic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease In-vitro Diagnostic Sales by Region
8.7.2 Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease In-vitro Diagnostic by Region(2020-2025)
9.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease In-vitro Diagnostic Production
9.4.1 North America Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease In-vitro Diagnostic Production
9.5.1 Europe Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease In-vitro Diagnostic Production (2020-2025)
9.6.1 Japan Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease In-vitro Diagnostic Production (2020-2025)
9.7.1 China Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BD
10.1.1 BD Basic Information
10.1.2 BD Infectious Disease In-vitro Diagnostic Product Overview
10.1.3 BD Infectious Disease In-vitro Diagnostic Product Market Performance
10.1.4 BD Business Overview
10.1.5 BD SWOT Analysis
10.1.6 BD Recent Developments
10.2 BioM?rieux SA
10.2.1 BioM?rieux SA Basic Information
10.2.2 BioM?rieux SA Infectious Disease In-vitro Diagnostic Product Overview
10.2.3 BioM?rieux SA Infectious Disease In-vitro Diagnostic Product Market Performance
10.2.4 BioM?rieux SA Business Overview
10.2.5 BioM?rieux SA SWOT Analysis
10.2.6 BioM?rieux SA Recent Developments
10.3 Abbott
10.3.1 Abbott Basic Information
10.3.2 Abbott Infectious Disease In-vitro Diagnostic Product Overview
10.3.3 Abbott Infectious Disease In-vitro Diagnostic Product Market Performance
10.3.4 Abbott Business Overview
10.3.5 Abbott SWOT Analysis
10.3.6 Abbott Recent Developments
10.4 Quidel Corporation
10.4.1 Quidel Corporation Basic Information
10.4.2 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Overview
10.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Market Performance
10.4.4 Quidel Corporation Business Overview
10.4.5 Quidel Corporation Recent Developments
10.5 OraSure Technologies, Inc.
10.5.1 OraSure Technologies, Inc. Basic Information
10.5.2 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Overview
10.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Market Performance
10.5.4 OraSure Technologies, Inc. Business Overview
10.5.5 OraSure Technologies, Inc. Recent Developments
10.6 Hologic, Inc. (Gen Probe)
10.6.1 Hologic, Inc. (Gen Probe) Basic Information
10.6.2 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Overview
10.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Market Performance
10.6.4 Hologic, Inc. (Gen Probe) Business Overview
10.6.5 Hologic, Inc. (Gen Probe) Recent Developments
10.7 Danaher
10.7.1 Danaher Basic Information
10.7.2 Danaher Infectious Disease In-vitro Diagnostic Product Overview
10.7.3 Danaher Infectious Disease In-vitro Diagnostic Product Market Performance
10.7.4 Danaher Business Overview
10.7.5 Danaher Recent Developments
10.8 QIAGEN
10.8.1 QIAGEN Basic Information
10.8.2 QIAGEN Infectious Disease In-vitro Diagnostic Product Overview
10.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Product Market Performance
10.8.4 QIAGEN Business Overview
10.8.5 QIAGEN Recent Developments
10.9 Roche
10.9.1 Roche Basic Information
10.9.2 Roche Infectious Disease In-vitro Diagnostic Product Overview
10.9.3 Roche Infectious Disease In-vitro Diagnostic Product Market Performance
10.9.4 Roche Business Overview
10.9.5 Roche Recent Developments
10.10 Siemens Healthineers AG
10.10.1 Siemens Healthineers AG Basic Information
10.10.2 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Overview
10.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Market Performance
10.10.4 Siemens Healthineers AG Business Overview
10.10.5 Siemens Healthineers AG Recent Developments
10.11 Bio-Rad Laboratories, Inc.
10.11.1 Bio-Rad Laboratories, Inc. Basic Information
10.11.2 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Overview
10.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Market Performance
10.11.4 Bio-Rad Laboratories, Inc. Business Overview
10.11.5 Bio-Rad Laboratories, Inc. Recent Developments
11 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global Infectious Disease In-vitro Diagnostic Market Size Forecast
11.2 Global Infectious Disease In-vitro Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease In-vitro Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease In-vitro Diagnostic Market Size Forecast by Region
11.2.4 South America Infectious Disease In-vitro Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease In-vitro Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Infectious Disease In-vitro Diagnostic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Infectious Disease In-vitro Diagnostic by Type (2026-2035)
12.1.2 Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Infectious Disease In-vitro Diagnostic by Type (2026-2035)
12.2 Global Infectious Disease In-vitro Diagnostic Market Forecast by Application (2026-2035)
12.2.1 Global Infectious Disease In-vitro Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Disease In-vitro Diagnostic
1.2 Key Market Segments
1.2.1 Infectious Disease In-vitro Diagnostic Segment by Type
1.2.2 Infectious Disease In-vitro Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Infectious Disease In-vitro Diagnostic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease In-vitro Diagnostic Product Life Cycle
3.3 Global Infectious Disease In-vitro Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease In-vitro Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease In-vitro Diagnostic Market Competitive Situation and Trends
3.8.1 Infectious Disease In-vitro Diagnostic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease In-vitro Diagnostic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease In-vitro Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease In-vitro Diagnostic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease In-vitro Diagnostic Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease In-vitro Diagnostic Market Size by Type (2020-2025)
6.4 Global Infectious Disease In-vitro Diagnostic Price by Type (2020-2025)
7 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease In-vitro Diagnostic Market Sales by Application (2020-2025)
7.3 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease In-vitro Diagnostic Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET SALES BY REGION
8.1 Global Infectious Disease In-vitro Diagnostic Sales by Region
8.1.1 Global Infectious Disease In-vitro Diagnostic Sales by Region
8.1.2 Global Infectious Disease In-vitro Diagnostic Sales Market Share by Region
8.2 Global Infectious Disease In-vitro Diagnostic Market Size by Region
8.2.1 Global Infectious Disease In-vitro Diagnostic Market Size by Region
8.2.2 Global Infectious Disease In-vitro Diagnostic Market Size by Region
8.3 North America
8.3.1 North America Infectious Disease In-vitro Diagnostic Sales by Country
8.3.2 North America Infectious Disease In-vitro Diagnostic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease In-vitro Diagnostic Sales by Country
8.4.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease In-vitro Diagnostic Sales by Region
8.5.2 Asia Pacific Infectious Disease In-vitro Diagnostic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease In-vitro Diagnostic Sales by Country
8.6.2 South America Infectious Disease In-vitro Diagnostic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease In-vitro Diagnostic Sales by Region
8.7.2 Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease In-vitro Diagnostic by Region(2020-2025)
9.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease In-vitro Diagnostic Production
9.4.1 North America Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease In-vitro Diagnostic Production
9.5.1 Europe Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease In-vitro Diagnostic Production (2020-2025)
9.6.1 Japan Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease In-vitro Diagnostic Production (2020-2025)
9.7.1 China Infectious Disease In-vitro Diagnostic Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease In-vitro Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BD
10.1.1 BD Basic Information
10.1.2 BD Infectious Disease In-vitro Diagnostic Product Overview
10.1.3 BD Infectious Disease In-vitro Diagnostic Product Market Performance
10.1.4 BD Business Overview
10.1.5 BD SWOT Analysis
10.1.6 BD Recent Developments
10.2 BioM?rieux SA
10.2.1 BioM?rieux SA Basic Information
10.2.2 BioM?rieux SA Infectious Disease In-vitro Diagnostic Product Overview
10.2.3 BioM?rieux SA Infectious Disease In-vitro Diagnostic Product Market Performance
10.2.4 BioM?rieux SA Business Overview
10.2.5 BioM?rieux SA SWOT Analysis
10.2.6 BioM?rieux SA Recent Developments
10.3 Abbott
10.3.1 Abbott Basic Information
10.3.2 Abbott Infectious Disease In-vitro Diagnostic Product Overview
10.3.3 Abbott Infectious Disease In-vitro Diagnostic Product Market Performance
10.3.4 Abbott Business Overview
10.3.5 Abbott SWOT Analysis
10.3.6 Abbott Recent Developments
10.4 Quidel Corporation
10.4.1 Quidel Corporation Basic Information
10.4.2 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Overview
10.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Market Performance
10.4.4 Quidel Corporation Business Overview
10.4.5 Quidel Corporation Recent Developments
10.5 OraSure Technologies, Inc.
10.5.1 OraSure Technologies, Inc. Basic Information
10.5.2 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Overview
10.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Market Performance
10.5.4 OraSure Technologies, Inc. Business Overview
10.5.5 OraSure Technologies, Inc. Recent Developments
10.6 Hologic, Inc. (Gen Probe)
10.6.1 Hologic, Inc. (Gen Probe) Basic Information
10.6.2 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Overview
10.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Market Performance
10.6.4 Hologic, Inc. (Gen Probe) Business Overview
10.6.5 Hologic, Inc. (Gen Probe) Recent Developments
10.7 Danaher
10.7.1 Danaher Basic Information
10.7.2 Danaher Infectious Disease In-vitro Diagnostic Product Overview
10.7.3 Danaher Infectious Disease In-vitro Diagnostic Product Market Performance
10.7.4 Danaher Business Overview
10.7.5 Danaher Recent Developments
10.8 QIAGEN
10.8.1 QIAGEN Basic Information
10.8.2 QIAGEN Infectious Disease In-vitro Diagnostic Product Overview
10.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Product Market Performance
10.8.4 QIAGEN Business Overview
10.8.5 QIAGEN Recent Developments
10.9 Roche
10.9.1 Roche Basic Information
10.9.2 Roche Infectious Disease In-vitro Diagnostic Product Overview
10.9.3 Roche Infectious Disease In-vitro Diagnostic Product Market Performance
10.9.4 Roche Business Overview
10.9.5 Roche Recent Developments
10.10 Siemens Healthineers AG
10.10.1 Siemens Healthineers AG Basic Information
10.10.2 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Overview
10.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Market Performance
10.10.4 Siemens Healthineers AG Business Overview
10.10.5 Siemens Healthineers AG Recent Developments
10.11 Bio-Rad Laboratories, Inc.
10.11.1 Bio-Rad Laboratories, Inc. Basic Information
10.11.2 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Overview
10.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Market Performance
10.11.4 Bio-Rad Laboratories, Inc. Business Overview
10.11.5 Bio-Rad Laboratories, Inc. Recent Developments
11 INFECTIOUS DISEASE IN-VITRO DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global Infectious Disease In-vitro Diagnostic Market Size Forecast
11.2 Global Infectious Disease In-vitro Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease In-vitro Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease In-vitro Diagnostic Market Size Forecast by Region
11.2.4 South America Infectious Disease In-vitro Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease In-vitro Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Infectious Disease In-vitro Diagnostic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Infectious Disease In-vitro Diagnostic by Type (2026-2035)
12.1.2 Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Infectious Disease In-vitro Diagnostic by Type (2026-2035)
12.2 Global Infectious Disease In-vitro Diagnostic Market Forecast by Application (2026-2035)
12.2.1 Global Infectious Disease In-vitro Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease In-vitro Diagnostic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Infectious Disease In-vitro Diagnostic Market Size by Type (M USD)
Table 4. Global Infectious Disease In-vitro Diagnostic Market Size by Application
Table 5. Infectious Disease In-vitro Diagnostic Market Size Comparison by Region (M USD)
Table 6. Global Infectious Disease In-vitro Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Infectious Disease In-vitro Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Infectious Disease In-vitro Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2025)
Table 11. Global Market Infectious Disease In-vitro Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Infectious Disease In-vitro Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease In-vitro Diagnostic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Infectious Disease In-vitro Diagnostic Sales by Type (K Units)
Table 27. Global Infectious Disease In-vitro Diagnostic Market Size by Type (M USD)
Table 28. Global Infectious Disease In-vitro Diagnostic Sales (K Units) by Type (2020-2025)
Table 29. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2020-2025)
Table 30. Global Infectious Disease In-vitro Diagnostic Market Size (M USD) by Type (2020-2025)
Table 31. Global Infectious Disease In-vitro Diagnostic Market Share by Type (2020-2025)
Table 32. Global Infectious Disease In-vitro Diagnostic Price (USD/Unit) by Type (2020-2025)
Table 33. Global Infectious Disease In-vitro Diagnostic Sales (K Units) by Application
Table 34. Global Infectious Disease In-vitro Diagnostic Market Size by Application
Table 35. Global Infectious Disease In-vitro Diagnostic Sales by Application (2020-2025) & (K Units)
Table 36. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2020-2025)
Table 37. Global Infectious Disease In-vitro Diagnostic Market Size by Application (2020-2025) & (M USD)
Table 38. Global Infectious Disease In-vitro Diagnostic Market Share by Application (2020-2025)
Table 39. Global Infectious Disease In-vitro Diagnostic Sales Growth Rate by Application (2020-2025)
Table 40. Global Infectious Disease In-vitro Diagnostic Sales by Region (2020-2025) & (K Units)
Table 41. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Region (2020-2025)
Table 42. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 43. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025)
Table 44. North America Infectious Disease In-vitro Diagnostic Sales by Country (2020-2025) & (K Units)
Table 45. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Infectious Disease In-vitro Diagnostic Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Infectious Disease In-vitro Diagnostic Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 50. South America Infectious Disease In-vitro Diagnostic Sales by Country (2020-2025) & (K Units)
Table 51. South America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 54. Global Infectious Disease In-vitro Diagnostic Production (K Units) by Region(2020-2025)
Table 55. Global Infectious Disease In-vitro Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2020-2025)
Table 57. Global Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. BD Basic Information
Table 63. BD Infectious Disease In-vitro Diagnostic Product Overview
Table 64. BD Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. BD Business Overview
Table 66. BD SWOT Analysis
Table 67. BD Recent Developments
Table 68. BioM?rieux SA Basic Information
Table 69. BioM?rieux SA Infectious Disease In-vitro Diagnostic Product Overview
Table 70. BioM?rieux SA Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. BioM?rieux SA Business Overview
Table 72. BioM?rieux SA SWOT Analysis
Table 73. BioM?rieux SA Recent Developments
Table 74. Abbott Basic Information
Table 75. Abbott Infectious Disease In-vitro Diagnostic Product Overview
Table 76. Abbott Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Business Overview
Table 78. Abbott SWOT Analysis
Table 79. Abbott Recent Developments
Table 80. Quidel Corporation Basic Information
Table 81. Quidel Corporation Infectious Disease In-vitro Diagnostic Product Overview
Table 82. Quidel Corporation Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Quidel Corporation Business Overview
Table 84. Quidel Corporation Recent Developments
Table 85. OraSure Technologies, Inc. Basic Information
Table 86. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Overview
Table 87. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. OraSure Technologies, Inc. Business Overview
Table 89. OraSure Technologies, Inc. Recent Developments
Table 90. Hologic, Inc. (Gen Probe) Basic Information
Table 91. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Overview
Table 92. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Hologic, Inc. (Gen Probe) Business Overview
Table 94. Hologic, Inc. (Gen Probe) Recent Developments
Table 95. Danaher Basic Information
Table 96. Danaher Infectious Disease In-vitro Diagnostic Product Overview
Table 97. Danaher Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Danaher Business Overview
Table 99. Danaher Recent Developments
Table 100. QIAGEN Basic Information
Table 101. QIAGEN Infectious Disease In-vitro Diagnostic Product Overview
Table 102. QIAGEN Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. QIAGEN Business Overview
Table 104. QIAGEN Recent Developments
Table 105. Roche Basic Information
Table 106. Roche Infectious Disease In-vitro Diagnostic Product Overview
Table 107. Roche Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Roche Business Overview
Table 109. Roche Recent Developments
Table 110. Siemens Healthineers AG Basic Information
Table 111. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Overview
Table 112. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Siemens Healthineers AG Business Overview
Table 114. Siemens Healthineers AG Recent Developments
Table 115. Bio-Rad Laboratories, Inc. Basic Information
Table 116. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Overview
Table 117. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bio-Rad Laboratories, Inc. Business Overview
Table 119. Bio-Rad Laboratories, Inc. Recent Developments
Table 120. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 121. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 123. North America Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 125. Europe Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Infectious Disease In-vitro Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 127. Asia Pacific Infectious Disease In-vitro Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 129. South America Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Type (2026-2035) & (K Units)
Table 133. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Infectious Disease In-vitro Diagnostic Price Forecast by Type (2026-2035) & (USD/Unit)
Table 135. Global Infectious Disease In-vitro Diagnostic Sales (K Units) Forecast by Application (2026-2035)
Table 136. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Infectious Disease In-vitro Diagnostic Market Size by Type (M USD)
Table 4. Global Infectious Disease In-vitro Diagnostic Market Size by Application
Table 5. Infectious Disease In-vitro Diagnostic Market Size Comparison by Region (M USD)
Table 6. Global Infectious Disease In-vitro Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Infectious Disease In-vitro Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Infectious Disease In-vitro Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2025)
Table 11. Global Market Infectious Disease In-vitro Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Infectious Disease In-vitro Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease In-vitro Diagnostic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Infectious Disease In-vitro Diagnostic Sales by Type (K Units)
Table 27. Global Infectious Disease In-vitro Diagnostic Market Size by Type (M USD)
Table 28. Global Infectious Disease In-vitro Diagnostic Sales (K Units) by Type (2020-2025)
Table 29. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Type (2020-2025)
Table 30. Global Infectious Disease In-vitro Diagnostic Market Size (M USD) by Type (2020-2025)
Table 31. Global Infectious Disease In-vitro Diagnostic Market Share by Type (2020-2025)
Table 32. Global Infectious Disease In-vitro Diagnostic Price (USD/Unit) by Type (2020-2025)
Table 33. Global Infectious Disease In-vitro Diagnostic Sales (K Units) by Application
Table 34. Global Infectious Disease In-vitro Diagnostic Market Size by Application
Table 35. Global Infectious Disease In-vitro Diagnostic Sales by Application (2020-2025) & (K Units)
Table 36. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2020-2025)
Table 37. Global Infectious Disease In-vitro Diagnostic Market Size by Application (2020-2025) & (M USD)
Table 38. Global Infectious Disease In-vitro Diagnostic Market Share by Application (2020-2025)
Table 39. Global Infectious Disease In-vitro Diagnostic Sales Growth Rate by Application (2020-2025)
Table 40. Global Infectious Disease In-vitro Diagnostic Sales by Region (2020-2025) & (K Units)
Table 41. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Region (2020-2025)
Table 42. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 43. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025)
Table 44. North America Infectious Disease In-vitro Diagnostic Sales by Country (2020-2025) & (K Units)
Table 45. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Infectious Disease In-vitro Diagnostic Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Infectious Disease In-vitro Diagnostic Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 50. South America Infectious Disease In-vitro Diagnostic Sales by Country (2020-2025) & (K Units)
Table 51. South America Infectious Disease In-vitro Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 54. Global Infectious Disease In-vitro Diagnostic Production (K Units) by Region(2020-2025)
Table 55. Global Infectious Disease In-vitro Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Region (2020-2025)
Table 57. Global Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Infectious Disease In-vitro Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. BD Basic Information
Table 63. BD Infectious Disease In-vitro Diagnostic Product Overview
Table 64. BD Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. BD Business Overview
Table 66. BD SWOT Analysis
Table 67. BD Recent Developments
Table 68. BioM?rieux SA Basic Information
Table 69. BioM?rieux SA Infectious Disease In-vitro Diagnostic Product Overview
Table 70. BioM?rieux SA Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. BioM?rieux SA Business Overview
Table 72. BioM?rieux SA SWOT Analysis
Table 73. BioM?rieux SA Recent Developments
Table 74. Abbott Basic Information
Table 75. Abbott Infectious Disease In-vitro Diagnostic Product Overview
Table 76. Abbott Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Business Overview
Table 78. Abbott SWOT Analysis
Table 79. Abbott Recent Developments
Table 80. Quidel Corporation Basic Information
Table 81. Quidel Corporation Infectious Disease In-vitro Diagnostic Product Overview
Table 82. Quidel Corporation Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Quidel Corporation Business Overview
Table 84. Quidel Corporation Recent Developments
Table 85. OraSure Technologies, Inc. Basic Information
Table 86. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Overview
Table 87. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. OraSure Technologies, Inc. Business Overview
Table 89. OraSure Technologies, Inc. Recent Developments
Table 90. Hologic, Inc. (Gen Probe) Basic Information
Table 91. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Overview
Table 92. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Hologic, Inc. (Gen Probe) Business Overview
Table 94. Hologic, Inc. (Gen Probe) Recent Developments
Table 95. Danaher Basic Information
Table 96. Danaher Infectious Disease In-vitro Diagnostic Product Overview
Table 97. Danaher Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Danaher Business Overview
Table 99. Danaher Recent Developments
Table 100. QIAGEN Basic Information
Table 101. QIAGEN Infectious Disease In-vitro Diagnostic Product Overview
Table 102. QIAGEN Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. QIAGEN Business Overview
Table 104. QIAGEN Recent Developments
Table 105. Roche Basic Information
Table 106. Roche Infectious Disease In-vitro Diagnostic Product Overview
Table 107. Roche Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Roche Business Overview
Table 109. Roche Recent Developments
Table 110. Siemens Healthineers AG Basic Information
Table 111. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Overview
Table 112. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Siemens Healthineers AG Business Overview
Table 114. Siemens Healthineers AG Recent Developments
Table 115. Bio-Rad Laboratories, Inc. Basic Information
Table 116. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Overview
Table 117. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bio-Rad Laboratories, Inc. Business Overview
Table 119. Bio-Rad Laboratories, Inc. Recent Developments
Table 120. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 121. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 123. North America Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 125. Europe Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Infectious Disease In-vitro Diagnostic Sales Forecast by Region (2026-2035) & (K Units)
Table 127. Asia Pacific Infectious Disease In-vitro Diagnostic Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (K Units)
Table 129. South America Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Type (2026-2035) & (K Units)
Table 133. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Infectious Disease In-vitro Diagnostic Price Forecast by Type (2026-2035) & (USD/Unit)
Table 135. Global Infectious Disease In-vitro Diagnostic Sales (K Units) Forecast by Application (2026-2035)
Table 136. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Disease In-vitro Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease In-vitro Diagnostic Market Size (M USD), 2025-2035
Figure 5. Global Infectious Disease In-vitro Diagnostic Market Size (M USD) (2020-2035)
Figure 6. Global Infectious Disease In-vitro Diagnostic Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease In-vitro Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease In-vitro Diagnostic Product Life Cycle
Figure 13. Infectious Disease In-vitro Diagnostic Sales Share by Manufacturers in 2025
Figure 14. Global Infectious Disease In-vitro Diagnostic Revenue Share by Manufacturers in 2025
Figure 15. Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Infectious Disease In-vitro Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease In-vitro Diagnostic Revenue in 2025
Figure 18. Industry Chain Map of Infectious Disease In-vitro Diagnostic
Figure 19. Global Infectious Disease In-vitro Diagnostic Market PEST Analysis
Figure 20. Global Infectious Disease In-vitro Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease In-vitro Diagnostic Market Share by Type
Figure 27. Sales Market Share of Infectious Disease In-vitro Diagnostic by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease In-vitro Diagnostic by Type in 2025
Figure 29. Market Share of Infectious Disease In-vitro Diagnostic by Type (2020-2025)
Figure 30. Market Share of Infectious Disease In-vitro Diagnostic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease In-vitro Diagnostic Market Share by Application
Figure 33. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Application in 2025
Figure 35. Global Infectious Disease In-vitro Diagnostic Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease In-vitro Diagnostic Market Share by Application in 2025
Figure 37. Global Infectious Disease In-vitro Diagnostic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025)
Figure 40. North America Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease In-vitro Diagnostic Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease In-vitro Diagnostic Market Size by Country in 2024
Figure 45. U.S. Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease In-vitro Diagnostic Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease In-vitro Diagnostic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease In-vitro Diagnostic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease In-vitro Diagnostic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease In-vitro Diagnostic Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease In-vitro Diagnostic Market Size by Country in 2024
Figure 55. Germany Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease In-vitro Diagnostic Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease In-vitro Diagnostic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease In-vitro Diagnostic Market Size by Region in 2024
Figure 68. China Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease In-vitro Diagnostic Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease In-vitro Diagnostic Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease In-vitro Diagnostic Market Size by Country in 2024
Figure 82. Brazil Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size by Region in 2024
Figure 92. Saudi Arabia Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease In-vitro Diagnostic Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Infectious Disease In-vitro Diagnostic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Infectious Disease In-vitro Diagnostic Market Share Forecast by Type (2026-2035)
Figure 111. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Application (2026-2035)
Figure 112. Global Infectious Disease In-vitro Diagnostic Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Infectious Disease In-vitro Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease In-vitro Diagnostic Market Size (M USD), 2025-2035
Figure 5. Global Infectious Disease In-vitro Diagnostic Market Size (M USD) (2020-2035)
Figure 6. Global Infectious Disease In-vitro Diagnostic Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease In-vitro Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease In-vitro Diagnostic Product Life Cycle
Figure 13. Infectious Disease In-vitro Diagnostic Sales Share by Manufacturers in 2025
Figure 14. Global Infectious Disease In-vitro Diagnostic Revenue Share by Manufacturers in 2025
Figure 15. Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Infectious Disease In-vitro Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease In-vitro Diagnostic Revenue in 2025
Figure 18. Industry Chain Map of Infectious Disease In-vitro Diagnostic
Figure 19. Global Infectious Disease In-vitro Diagnostic Market PEST Analysis
Figure 20. Global Infectious Disease In-vitro Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease In-vitro Diagnostic Market Share by Type
Figure 27. Sales Market Share of Infectious Disease In-vitro Diagnostic by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease In-vitro Diagnostic by Type in 2025
Figure 29. Market Share of Infectious Disease In-vitro Diagnostic by Type (2020-2025)
Figure 30. Market Share of Infectious Disease In-vitro Diagnostic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease In-vitro Diagnostic Market Share by Application
Figure 33. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Application in 2025
Figure 35. Global Infectious Disease In-vitro Diagnostic Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease In-vitro Diagnostic Market Share by Application in 2025
Figure 37. Global Infectious Disease In-vitro Diagnostic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease In-vitro Diagnostic Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease In-vitro Diagnostic Market Size by Region (2020-2025)
Figure 40. North America Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease In-vitro Diagnostic Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease In-vitro Diagnostic Market Size by Country in 2024
Figure 45. U.S. Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease In-vitro Diagnostic Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease In-vitro Diagnostic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease In-vitro Diagnostic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease In-vitro Diagnostic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease In-vitro Diagnostic Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease In-vitro Diagnostic Market Size by Country in 2024
Figure 55. Germany Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease In-vitro Diagnostic Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease In-vitro Diagnostic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease In-vitro Diagnostic Market Size by Region in 2024
Figure 68. China Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease In-vitro Diagnostic Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease In-vitro Diagnostic Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease In-vitro Diagnostic Market Size by Country in 2024
Figure 82. Brazil Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease In-vitro Diagnostic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease In-vitro Diagnostic Market Size by Region in 2024
Figure 92. Saudi Arabia Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease In-vitro Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease In-vitro Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease In-vitro Diagnostic Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease In-vitro Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Infectious Disease In-vitro Diagnostic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Infectious Disease In-vitro Diagnostic Market Share Forecast by Type (2026-2035)
Figure 111. Global Infectious Disease In-vitro Diagnostic Sales Forecast by Application (2026-2035)
Figure 112. Global Infectious Disease In-vitro Diagnostic Market Share Forecast by Application (2026-2035)
